Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Adjuvant Osimertinib: A New Standard of Care.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Adjuvant Osimertinib: A New Standard of Care.
Adjuvant Osimertinib: A New Standard of Care. Oncologist. 2021 04; 26(4):263-265.
View in:
PubMed
subject areas
Acrylamides
Aniline Compounds
Humans
Lung Neoplasms
Protein Kinase Inhibitors
Standard of Care
authors with profiles
Michael Jelinek